Novavax reported $10.01M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Adma Biologics USD 239.31M 17.22M Jun/2026
AstraZeneca USD 6.93B 362M Jun/2026
BioCryst Pharmaceuticals USD 6.06M 71K Jun/2026
Geron USD 123.6M 9.68M Jun/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
MannKind USD 44.42M 4.75M Jun/2026
Merck USD 6.21B 272M Jun/2026
Moderna USD 280M 134M Jun/2026
Novartis USD 6.29B 135M Mar/2026
Novavax USD 10.01M 1.45M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Sanofi EUR 24.12B 620M Jun/2026
Sarepta Therapeutics USD 904.27M 96.84M Jun/2026
TG Therapeutics USD 147.97M 18.94M Jun/2026